CAD & Atherosclerosis
News
Statins linked to lower physical activity
Key clinical point: Statin use in older men may have the consequence of reducing their physical activity.
Conference Coverage
Testosterone therapy may not be associated with CV risk
Conference Coverage
Evolocumab lowers LDL-C with no effect on glucose metabolism
Major finding: Evolocumab was associated with a reduction in LDL-C levels (–47% to –52%), compared with standard of care (0%), without any...
Conference Coverage
20-study analysis finds no MACE increase with saxagliptin
Major finding: The incidence of MACE composite endpoint was similar among patients treated with saxagliptin (0.85/100 person-years) and controls (...
News
Adding evolocumab to statins further lowered LDL cholesterol
Major finding: Of patients who received additive evolocumab, 86%-94% achieved LDL-cholesterol levels of less than 70 mg/dL, compared with only 17...
News from the FDA/CDC
FDA approves first-in-class oral antiplatelet drug vorapaxar
The novel antiplatelet drug vorapaxar has been approved for reducing the risk of myocardial infarction, stroke, cardiovascular death, and need for...
News
FDA declines to approve IV antiplatelet drug cangrelor
Conference Coverage
GERD may boost risk of MI
Major finding: GERD was found to be independently associated with a 57% increased risk of acute MI.Data source: This was a case-control study that...
News
Coronary artery calcification can guide aspirin therapy
Major finding: Compared with study subjects who had a CAC score of 0, those with CAC scores of 100 or higher had more than a ninefold higher risk...
News
New omega-3-fatty acid approved for severe hypertriglyceridemia
Conference Coverage
Significant improvements in adherence, blood pressure, and LDL cholesterol with polypill
Major finding: A four-drug polypill significantly improves adherence, and reduces blood pressure and LDL cholesterol in patients with existing...